The Filing Desk

Alpha Pro Tech vs Organogenesis

Alpha Pro Tech APT · Organogenesis ORGO · Health Care Supplies

Organogenesis reported revenue of $564 million in fiscal 2025, 9.5 times Alpha Pro Tech's $59 million in fiscal 2025. Alpha Pro Tech's revenue grew 2.2% in its latest year, and Organogenesis' grew 17.0%. Alpha Pro Tech had an operating margin of 6.5%, against 7.9% at Organogenesis. Free cash flow was $2 million at Alpha Pro Tech and −$24 million at Organogenesis.

Side by side

Alpha Pro TechOrganogenesis
Latest fiscal yearFY2025, Dec 31, 2025FY2025, Dec 31, 2025
Revenue$59M$564M
Revenue growth2.2%17.0%
Revenue growth a year, last 5 years−10.5%10.8%
Gross margin38.1%—
Operating margin6.5%7.9%
Net margin6.0%6.6%
Free cash flow$2M−$24M
Free cash flow margin2.9%−4.3%
Return on capital——
Net debt to EBITDA——
Dividends and buybacks$3M$0M
Change in diluted share count−6.1%−1.1%
Last close$6.24$0.79
P/E at the last close12.5×—
Insider trades, last 12 monthssold $417,209bought $40,100, sold $2.6 million
Piotroski F-score——
Amounts in each company's own currency, US$ unless marked (a foreign company may report in another), each company's latest fiscal year from its 10-K, or 20-F or 40-F for a foreign company. Growth rates compare with the year before; the five-year rate is the average a year. Free cash flow is cash from operations minus capital spending; return on capital is after-tax operating income over the money invested in the business; P/E is the last close over the latest earnings per share. Banks are measured differently (return on equity, efficiency ratio), so some rows apply to one company only.

Ten years

Revenue
US$ billions, fiscal years
Alpha Pro TechOrganogenesis
Operating margin
Percent of revenue
Alpha Pro TechOrganogenesis
Free cash flow
US$ billions. Cash from operations minus capital expenditure.
Alpha Pro TechOrganogenesis

Start a new comparison

Source: the companies' Form 10-K filings, from SEC EDGAR, and the last close. For information only, not investment advice: the figures describe results, not which company is the better investment. The Filing Desk is not affiliated with either company. Full figures on the Alpha Pro Tech and Organogenesis pages.